PMA device
Flash Glucose Monitoring System
Abbott Diabetes Care, Inc. · Sensor, Glucose, Invasive (MDS, Class III) · First FDA decision Dec 21, 2018, newest Apr 5, 2019Diabetes
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
PMA pathway
Device trials
195
Naming "Flash"
MAUDE reports
681
Brand "Flash", since 2015
PubMed studies
27,717
Mentioning "Flash"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Flash Glucose Monitoring System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- Flash Glucose Monitoring SystemPMA supplement
P150021-S036 · Decided Apr 5, 2019 · 156 days after receipt · Normal 180 Day Track
Device type: Sensor, glucose, invasive (MDS) · Laboratory Medicine & Pathology
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Flash", any status and sponsor, newest update first.
- Glucose Pattern in Infertile Women Receiving Assisted Reproduction Using Continuous Glucose MonitoringActive, not recruiting
Shanghai 6th People's HospitalAcademic, hospital or other
NCT06863337 · 100 participants (planned) · Start Mar 26, 2025 · Primary completion Jun 30, 2026
Device: CGM · For: Infertility Female
Sites: Shanghai, China
194 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Flash", and for the whole product code for context.
This brand
681 reports: 528 malfunction, 115 injury, 35 death
Whole product code MDS
232,139 reports: 226,671 malfunction, 5,201 injury, 215 death
Newest reports for this brand
3005168196-2026-00354 · Received Oct 15, 2026 · Event dated Sep 23, 2026
Device type: Peripheral Mechanical Thrombectomy With Aspiration (QEW)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Hemorrhage/Blood Loss/Bleeding
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Flash"[tiab]. The summary above synthesizes these.
- FLASH radiotherapy: A new milestone in the field of cancer radiotherapy.
Tang R, Yin J, Liu Y, et al. · Cancer Lett · 2024Review, Research Support, Non-U.S. Gov't
- FLASH radiation reprograms lipid metabolism and macrophage immunity and sensitizes medulloblastoma to CAR-T cell therapy.
Ni H, Reitman ZJ, Zou W, et al. · Nat Cancer · 2025
- FLASH Radiotherapy: Current Knowledge and Future Insights Using Proton-Beam Therapy.
Hughes JR, Parsons JL · Int J Mol Sci · 2020Review
- Democratizing FLASH Radiotherapy.
Moreau M, Mao S, Ngwa U, et al. · Semin Radiat Oncol · 2024Review
- FLASH radiotherapy with photon beams.
Montay-Gruel P, Corde S, Laissue JA, et al. · Med Phys · 2022Review
- Evaluation of a protocol for fast localised abdominal sonography of horses (FLASH) admitted for colic.
Busoni V, De Busscher V, Lopez D, et al. · Vet J · 2011Evaluation Study
- Mechanisms, challenges and opportunities for FLASH radiotherapy in cancer.
Vozenin MC, Montay-Gruel P, Tsoutsou P, et al. · Nat Rev Cancer · 2026Review
- FLASH Radiotherapy: History and Future.
Lin B, Gao F, Yang Y, et al. · Front Oncol · 2021Review
- Flash mob: a multidisciplinary review.
Al-Khateeb S, Agarwal N · Soc Netw Anal Min · 2021Review
- Mechanisms of FLASH effect.
Lin B, Huang D, Gao F, et al. · Front Oncol · 2022Review
- Implications of "flash" radiotherapy for biodosimetry.
Swarts SG, Flood AB, Swartz HM · Radiat Prot Dosimetry · 2023
- FLASH Effects Induced by Orthovoltage X-Rays.
Miles D, Sforza D, Wong JW, et al. · Int J Radiat Oncol Biol Phys · 2023Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code MDS.
- Dexcom G4 Platinum Continuous Glucose Monitoring System and Dexcom 5 Mobile Continuous Glucose Monitoring SystemDexcom, Inc. · PMA 2018
- G5 Mobile Continuous Glucose Monitoring SystemDexcom, Inc. · PMA 2024
- FreeStyle Libre Pro Flash Glucose Monitoring SystemAbbott Diabetes Care, Inc. · PMA 2020
- Freestyle Navigator Continuous Glucose Monitoring SystemAbbott Laboratories · PMA 2011
- Paradigm Real-Time Insulin PumpMedtronic Minimed · PMA 2015
- Medtronic Minimed Continuous Glucose Monitoring SystemMedtronic Minimed · PMA 2011
- Guardian Connect SystemMedtronic Minimed · PMA 2025
- Dexcom Seven SystemDexcom, Inc. · PMA 2009
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.